sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 2020-2027

Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal...

Home / Categories / Healthcare
Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 2020-2027
Hemodialysis and Peritoneal Dialysis Market...
Report Code
RO1/113/1739

Publish Date
30/Dec/2020

Pages
262
PRICE
$ 6269/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 7050/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 9832/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter's five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Surge in incidences of kidney diseases
3.5.1.2.Issues associated with kidney transplants
3.5.1.3.Rise in prevalence of lifestyle and chronic diseases

3.5.2.Restraints

3.5.2.1.Complications in dialysis treatment
3.5.2.2.Reimbursement policy concerns in emerging nations

3.5.3.Opportunities

3.5.3.1.Shift in preference of patients for home hemodialysis
3.5.3.2.Surge in market strategies by key players

3.6.Prevalence and Incidence of HD and PD: Important demographics
3.7.Pricing analysis
3.8.Average survival time of vascular access products
3.9.Reimbursement scenario for dialysis (per patient)
3.10.List of major morbidities associated with hemodialysis access procedures
3.11.List of major companies delivering dialysis services

CHAPTER 4:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Hemodialysis (HD)

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Short-term Catheter (Non-cuffed tunneled catheters)
4.2.5.Chronic Catheter (Cuffed tunneled catheters)
4.2.6.Graft (AVG)
4.2.7.Fistula (AVF)

4.3.Peritoneal dialysis (PD)

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country

CHAPTER 5:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals

5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.Clinics & dialysis centers

5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

5.4.Home dialysis

5.4.1.Key market trends and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.4.4.Market share analysis, by type

5.4.4.1. Home Hemodialysis

5.4.4.1.1.Market size and forecast, by region
5.4.4.1.2.Market share analysis, by country

5.4.4.2. Home Peritoneal Dialysis

5.4.4.2.1.Market size and forecast, by region
5.4.4.2.2.Market share analysis, by country

CHAPTER 6:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY

6.1.Overview

6.1.1.Market size and forecast

6.2.Conventional dialysis

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market share analysis, by country

6.3.Daily dialysis (Day time/ Night time)

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market share analysis, by country

CHAPTER 7:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT

7.1.Overview

7.1.1.Market size and forecast

7.2.Devices

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.2.3.Market share analysis, by country

7.3.Consumables

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.3.3.Market share analysis, by country

CHAPTER 8:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.Market size and forecast, by country
8.2.3.Market size and forecast, by type
8.2.4.Market size and forecast, by dialysis site
8.2.5.Market size and forecast, by modality
8.2.6.Market size and forecast, by product
8.2.7.U.S.

8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by dialysis site
8.2.7.3.Market size and forecast, by modality
8.2.7.4.Market size and forecast, by product

8.2.8.Canada

8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by dialysis site
8.2.8.3.Market size and forecast, by modality
8.2.8.4.Market size and forecast, by product

8.2.9.Mexico

8.2.9.1.Market size and forecast, by type
8.2.9.2.Market size and forecast, by dialysis site
8.2.9.3.Market size and forecast, by modality
8.2.9.4.Market size and forecast, by product

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Market size and forecast, by country
8.3.3.Market size and forecast, by type
8.3.4.Market size and forecast, by dialysis site
8.3.5.Market size and forecast, by modality
8.3.6.Market size and forecast, by product
8.3.7.UK

8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by dialysis site
8.3.7.3.Market size and forecast, by modality
8.3.7.4.Market size and forecast, by product

8.3.8.France

8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by dialysis site
8.3.8.3.Market size and forecast, by modality
8.3.8.4.Market size and forecast, by product

8.3.9.Spain

8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by dialysis site
8.3.9.3.Market size and forecast, by modality
8.3.9.4.Market size and forecast, by product

8.3.10.Italy

8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by dialysis site
8.3.10.3.Market size and forecast, by modality
8.3.10.4.Market size and forecast, by product

8.3.11.Germany

8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by dialysis site
8.3.11.3.Market size and forecast, by modality
8.3.11.4.Market size and forecast, by product

8.3.12.Rest of Europe

8.3.12.1.Market size and forecast, by type
8.3.12.2.Market size and forecast, by dialysis site
8.3.12.3.Market size and forecast, by modality
8.3.12.4.Market size and forecast, by product

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Market size and forecast, by country
8.4.3.Market size and forecast, by type
8.4.4.Market size and forecast, by dialysis site
8.4.5.Market size and forecast, by modality
8.4.6.Market size and forecast, by product
8.4.7.Japan

8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by dialysis site
8.4.7.3.Market size and forecast, by modality
8.4.7.4.Market size and forecast, by product

8.4.8.China

8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by dialysis site
8.4.8.3.Market size and forecast, by modality
8.4.8.4.Market size and forecast, by product

8.4.9.Australia

8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by dialysis site
8.4.9.3.Market size and forecast, by modality
8.4.9.4.Market size and forecast, by product

8.4.10.India

8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by dialysis site
8.4.10.3.Market size and forecast, by modality
8.4.10.4.Market size and forecast, by product

8.4.11.South Korea

8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by dialysis site
8.4.11.3.Market size and forecast, by modality
8.4.11.4.Market size and forecast, by product

8.4.12.Rest of Asia-Pacific

8.4.12.1.Market size and forecast, by type
8.4.12.2.Market size and forecast, by dialysis site
8.4.12.3.Market size and forecast, by modality
8.4.12.4.Market size and forecast, by product

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.Market size and forecast, by country
8.5.3.Market size and forecast, by type
8.5.4.Market size and forecast, by dialysis site
8.5.5.Market size and forecast, by modality
8.5.6.Market size and forecast, by product
8.5.7.Brazil

8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by dialysis site
8.5.7.3.Market size and forecast, by modality
8.5.7.4.Market size and forecast, by product

8.5.8.Saudi Arabia

8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by dialysis site
8.5.8.3.Market size and forecast, by modality
8.5.8.4.Market size and forecast, by product

8.5.9.South Africa

8.5.9.1.Market size and forecast, by type
8.5.9.2.Market size and forecast, by dialysis site
8.5.9.3.Market size and forecast, by modality
8.5.9.4.Market size and forecast, by product

8.5.10.Rest of LAMEA

8.5.10.1.Market size and forecast, by type
8.5.10.2.Market size and forecast, by dialysis site
8.5.10.3.Market size and forecast, by modality
8.5.10.4.Market size and forecast, by product

CHAPTER 9:COMPANY PROFILES

9.1.FRESENIUS SE AND CO. KGAA

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.ASAHI KASEI CORPORATION

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance

9.3.B. BRAUN MELSUNGEN AG

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments

9.4.BAXTER INTERNATIONAL INC.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments

9.6.COOK GROUP

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio

9.7.ANGIODYNAMICS INC.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance

9.8.MEDTRONIC PLC.

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.NIKKISO CO. LTD.

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance

9.10.NIPRO CORPORATION

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com